A young crowd eager to attend Harry Styles concert in Boston, but are there any COVID issues? – CBS Boston

BOSTON (CBS) – A young crowd of thousands of teens and twenties, draped in 1970s feather boas and bell stockings, flocked to TD Garden on Monday night for the Harry Styles “Love on Tour” concert. “.

The concert had been sold out for months, and resale prices were only $ 2,700 per ticket on the night of the show.

READ MORE: Concord-Carlisle high school teacher accused of using racist slurs put on leave

On the neck of the fans? Not VIP lanyards, but their vaccination cards.

In order to enter the TD Garden for any event, fans need proof of vaccination or a negative COVID-19 test. All fans must wear masks indoors, regardless of vaccination status.

“Big crowds make me a little anxious, but having my vaccine is like OK, I know I’ll be safer than someone who doesn’t have the vaccine,” a fan told WBZ.

READ MORE: Nor’east will bring heavy rains, high winds and possible flooding to southern New England

Unlike the Bruins games or the Eagles concert last summer, hundreds of Harry Styles spectators were not yet old enough to be vaccine-eligible and instead had to take a negative COVID test to see their all. first concert.

Tufts Medical Center epidemiologist Dr Shira Doron explained the risks of a crowded indoor event with many unvaccinated people.

“People too young to get vaccinated are also protected by their youth, so could the concert be a great broadcast event? It could. Could there be transmission in an indoor environment with many people close to each other? He could. But I think everyone these days is aware of that risk, ”she said. “Ensuring that a large portion of this population is vaccinated significantly reduces the risk of a person becoming infected. “

Dr Doron explained that wearing masks, along with the general trend towards fewer hospitalizations, makes an event like the concert less risky.

NO MORE NEWS: Security guard to plead guilty to stabbing Timberland employee Catherine Heppner

An independent FDA vaccine expert panel plans to expand Pfizer’s vaccine to cover children ages 5 to 11 in a discussion on Tuesday, which could pave the way for vaccine approval in younger age groups as a result of a Pfizer study that showed high efficacy in children.